VU6067416 is an indazole derivative which acts as an agonist for the 5-HT2 family of serotonin receptors. It is a potent full agonist at 5-HT2B, and has slightly lower affinity and partial agonist effects at 5-HT2A and 5-HT2C,[1] though some related compounds have improved selectivity for 5-HT2A.[2]
Identifiers | |
---|---|
| |
PubChem CID | |
Chemical and physical data | |
Formula | C12H12BrN3 |
Molar mass | 278.153 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ Jayakodiarachchi N, Maurer MA, Schultz DC, Dodd CJ, Thompson Gray A, Cho HP, et al. (January 2024). "Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists". ACS Medicinal Chemistry Letters. doi:10.1021/acsmedchemlett.3c00566. PMC 10860182.
- ^ Kargbo RB (November 2023). "Small-Molecule Heterocyclic Compounds: Gq-Biased Agonists for the 5-HT2A Receptor in Neuropsychiatric Treatment". ACS Medicinal Chemistry Letters. 14 (11): 1498–1500. doi:10.1021/acsmedchemlett.3c00444. PMID 37974947.